Methods for randomized, blinded, controlled evaluation of putative disease interventions in multi-laboratory, preclinical assessment networks

Karisma Nagarkatti(Keck Hospital of USC), Jessica Lamb(Keck Hospital of USC), Anil K. Chauhan(University of Iowa), Mariia Kumskova(University of Iowa), Mohammad Badruzzaman Khan(Augusta University), Cenk Ayata(Massachusetts General Hospital), David C. Hess(Augusta University), Márcio A. Diniz(Cedars-Sinai Medical Center), Ryan P. Cabeen(Keck Hospital of USC), Enrique C. Leira(University of Iowa), Rakeshkumar Patel(Carver Bible College), Patrick D. Lyden(Keck Hospital of USC), André Rogatko(Cedars-Sinai Medical Center), Monica Estrada(Keck Hospital of USC), Sungjin Kim(Cedars-Sinai Medical Center), Karen Crawford(University of Glasgow)
Research Square
January 10, 2025
10.21203/rs.3.rs-3054771/v1
Cited by 0

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
|New England Journal of Medicine|1992|666
Racial-Ethnic Disparities in Stroke Care: The American Experience
|Stroke|2011|516
Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group
|Journal of Cerebral Blood Flow & Metabolism|2016|352
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
|The Lancet Neurology|2019|249